Immunogenic Reaction
Wanted
immunogenicity is often connected with vaccines, wherever the injection of A substance (the vaccine) provokes A response against the
microorganism (virus, bacteria), protective the organism from future exposure. Immunogenic development could be a advanced multi-step method, with
immunogenicity being at the middle of immunogen effectiveness.
Unwanted
immunogenicity is a response by an organism against a therapeutic substance (ex. recombinant macromolecule, or organism antibody). This reaction ends up in production of anti-drug-antibodies (ADAs) inactivating the therapeutic effects of the treatment and, in rare cases, causation adverse effects
A challenge in biotherapy is predicting the immunogenic potential of novel macromolecule medicine. as an example,
immunogenicity information from high-income countries aren't forever transferable to low-income and middle-income countries. Another challenge is considering however the
immunogenicity of vaccines changes with age. Therefore, as expressed by the globe
Health Organization,
immunogenicity ought to be investigated in a very target population since animal testing and in-vitro models cannot exactly predict response in humans. Immune response in humans.
High Impact List of Articles
-
An experimental study to check immediate effect of stacked breathing exercise on peak expiratory flow rate in cardiac surgery patient-pilot study
Rekha B Marbate*, Abhijit D Diwate and Arijit K Das
Research Article: Clinical Practice
-
An experimental study to check immediate effect of stacked breathing exercise on peak expiratory flow rate in cardiac surgery patient-pilot study
Rekha B Marbate*, Abhijit D Diwate and Arijit K Das
Research Article: Clinical Practice
-
Regulatory function of macroscopic quantum states of electrons in cell metabolism
Anatoly Stekhin, Galina Yakovleva, Konstantin Pronko & Vladimir Zemskov*
Research Article: Clinical Practice
-
Regulatory function of macroscopic quantum states of electrons in cell metabolism
Anatoly Stekhin, Galina Yakovleva, Konstantin Pronko & Vladimir Zemskov*
Research Article: Clinical Practice
-
Comparison of the therapeutic efficacy of 0.1% olopatadine hydrochloride and 0.025% ketotifen fumarate in allergic conjunctivitis
Shah-Jalal Sarker, Abu Nayeem Chowdhury, Zahid Hussain, AKM Mosharrof Hossain and Hashem Chowdhury
Research Article: Clinical Practice
-
Comparison of the therapeutic efficacy of 0.1% olopatadine hydrochloride and 0.025% ketotifen fumarate in allergic conjunctivitis
Shah-Jalal Sarker, Abu Nayeem Chowdhury, Zahid Hussain, AKM Mosharrof Hossain and Hashem Chowdhury
Research Article: Clinical Practice
-
Role of cytoreductive surgery in recurrent ovarian cancer
Anna Fagotti, Valerio Gallotta, Federico Romano, Francesco Fanfani, Cristiano Rossitto, Giuseppe Vizzielli, Barbara Costantini and Giovanni Scambia
Review Article: Clinical Practice
-
Role of cytoreductive surgery in recurrent ovarian cancer
Anna Fagotti, Valerio Gallotta, Federico Romano, Francesco Fanfani, Cristiano Rossitto, Giuseppe Vizzielli, Barbara Costantini and Giovanni Scambia
Review Article: Clinical Practice
-
Clinical application of extended-release hydromorphone for pain management
Jay S Grider
Drug Evaluation: Clinical Practice
-
Clinical application of extended-release hydromorphone for pain management
Jay S Grider
Drug Evaluation: Clinical Practice
-
Author Guidelines: Volume 5 Issue 3
Appendices: Clinical Practice
-
Author Guidelines: Volume 5 Issue 3
Appendices: Clinical Practice
-
Author guidelines: Volume 5 Issue 2
Appendices: Clinical Practice
-
Author guidelines: Volume 5 Issue 2
Appendices: Clinical Practice
-
Long-term outcome of pulmonary embolism
Guy Meyer, Benjamin Planquette and Olivier Sanchez
Review Article: Clinical Practice
-
Long-term outcome of pulmonary embolism
Guy Meyer, Benjamin Planquette and Olivier Sanchez
Review Article: Clinical Practice
Relevant Topics in Clinical